Why the study?
Does plasma ACE2 activity differ between haemodialysis patients and CKD patients, and does it vary by gender?
Does plasma ACE2 activity differ between haemodialysis patients and CKD patients, and does it vary by gender?
Plasma ACE2 activity is lower in haemodialysis patients than in CKD patients, with further reductions in females, suggesting a potential gender-specific role in cardiovascular disease.
Plasma ACE2 activity is reduced in haemodialysis patients compared with CKD patients, and in female haemodialysis patients compared with male. The different associations of plasma ACE2 activity between male and female haemodialysis patients indicate that the role of ACE2 in cardiovascular disease may differ by gender.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: